相关实验视频
Updated: Jul 18, 2026
07:47
Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis
Published on: June 26, 2016
10.2K
巨细胞介导的细胞通信网络在肺状细胞癌和腺癌中通过单细胞测序揭示了单细胞测序
Xiaoyu Zhang1, Yunlong Zhao1, Yingying Wang1
1Laboratory of Gene Engineering and Genomics, School of Basic Medical Sciences, Chengde Medical University, Chengde, 067000, China, cdmc.edu.cn.
Mediators of inflammation
|February 18, 2026
概括
这项研究揭示了肺状细胞癌 (LUSC) 和肺腺癌 (LUAD) 中明显的表皮特征和瘤微环境相互作用. 针对个性化免疫疗法,确定了关键的信号通路和治疗点,如CD44和CD74.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 非小细胞肺癌 (NSCLC),包括肺状细胞癌 (LUSC) 和肺腺癌 (LUAD),呈现出显著的异质性和死亡率.
- 了解瘤微环境 (TME) 和细胞交叉通话对于开发有效治疗非常重要.
研究的目的:
- 探索LUSC和LUAD的独特瘤微环境 (TME) 特性.
- 在NSCLC TME中识别亚型特定的细胞相互作用和潜在的治疗点.
主要方法:
- 使用scRNA-seq和TCGA批量RNA-seq数据进行全面分析.
- 应用细胞聚类,伪时间轨迹,细胞间通信 (CellChat) 和生存分析.
- 进行批量校正,质量控制,细胞类型注释 (SingleR) 和副本数变异推断 (InferCNV).
主要成果:
- 确定了四个上皮特征 (S1-S4),其中S3是LUSC特异性的,与较高恶性瘤相关.
- 揭示了LUSC (S2→S1→S3/S4) 和LUAD (S4→S1→S2) 的不同的分化轨迹.
- 发现的亚型特异性相互作用:LUSC (S3-巨通过SPP1/MIF) 和LUAD (S4-中性细胞通过MIF). 确定了关键的体受体对 (LUSC中的SPP1-CD44,LUAD中的RESISTIN-CAP1) 和预后标记 (LUSC中的CD44,LUAD中的CD74).
结论:
- 突出显示了特定亚型的表皮特征和TME通信通路 (例如MIF).
- 确定了CD44和CD74作为LUSC和LUAD的潜在治疗点.
- 提供了对不同的致病机制的见解,支持针对NSCLC亚型的个性化免疫疗法.
相关概念视频
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...